Mechanisms of multidrug resistance in cancer.

By J. Gillet, Michael M. Gottesman. Methods in molecular biology, 2010

690 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/195698a307046f6e478523a9f50c85dc4ffcb6db

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Matthew D. Hall
2. Lynn M. Pouliot
3. D. Shen
4. Michael M. Gottesman

In Oncology

1. Matthew D. Hall
2. Lynn M. Pouliot
3. D. Shen
4. Zhesheng Chen
5. Michael M. Gottesman

Citations in the corpus

• Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes (2012, background): “…cassette transporter known for years as P-glycoprotein or MDR1, functions as a pump to efflux a variety of structurally unrelated anticancer drugs, leading to cellular resistance to re- lated substrates but not to cisplatin (Gottesman et al., 2002; Gottesman, 2002; Gillet and Gottesman, 2010).”
• The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. (2015, background): “The mechanisms that cancer cells utilize or develop to evade chemotherapy are complex and have been described in detail in several recent reviews (Gillet and Gottesman, 2010; Gottesman et al., 2002; Szakacs et al., 2006).”